Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy

Biomaterials

Volumn 32, Issue 7, 2011, Pages 1890-1905

  Yallapu, Murali M ^a   Othman, Shadi F ^b   Curtis, Evan T ^b   Gupta, Brij K ^a   Jaggi, Meena ^a,c   Chauhan, Subhash C ^a,c  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Drug delivery; Hyperthermia; Magnetic nanoparticles; MRI; Multi layer coating

Indexed keywords

AGAR GEL; ALTERNATING MAGNETIC FIELD; ANTICANCER DRUG; CANCER CELLS; CANCER THERAPY; CIS-PLATIN; COATED NANOPARTICLES; CURCUMIN; DRUG DELIVERY APPLICATIONS; HAEMOCOMPATIBILITY; HYPERTHERMIA; IMAGING CONTRAST; INHIBITION EFFECT; IRON SALTS; MAGNETIC NANOPARTICLES; MOLECULAR EFFECT; MRI; MULTI-FUNCTIONAL; MULTI-LAYER-COATING; OVARIAN CANCER CELLS; PLURONICS; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUSTAINED DRUG RELEASE; TEM; THERAPEUTIC EFFECTS; TRANSMISSION ELECTRON; WATER DISPERSIBLE; WESTERN BLOTTING;

CELLS; DRUG DELIVERY; DRUG PRODUCTS; IRON OXIDES; MAGNETIC FIELD EFFECTS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; ONCOLOGY; PLASTIC COATINGS; PLATINUM COMPOUNDS; PRECIPITATION (CHEMICAL); RESONANCE; SUPERPARAMAGNETISM;

NANOMAGNETICS;

AMMONIA; BETA CYCLODEXTRIN; CISPLATIN; CURCUMIN; IRON SALT; NANOCOATING; POLOXAMER; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CANCER THERAPY; DRUG FORMULATION; DRUG PROTEIN BINDING; DRUG RELEASE; GEL; HUMAN; INDUCED HYPOTHERMIA; INTERNALIZATION; MACROPHAGE; MAGNETIC FIELD; MALE; MORPHOLOGY; NANOENCAPSULATION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; SYNTHESIS; ZETA POTENTIAL;

BETA-CYCLODEXTRINS; BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; HYPERTHERMIA, INDUCED; MAGNETIC RESONANCE IMAGING; MAGNETICS; NANOPARTICLES; NEOPLASMS;

EID: 78650978323     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.11.028     Document Type: Article

References (68)

1. Lu A.H., Salabas E.L., Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl 2007, 46:1222-1244.
2. Ito A., Shinkai M., Honda H., Kobayashi T. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 2005, 100:1-11.
3. Saiyed Z., Telang S., Ramchand C. Application of magnetic techniques in the field of drug discovery and biomedicine. Biomagn Res Technol 2003, 1:2.
4. Namdeo M., Saxena S., Tankhiwale R., Bajpai M., Mohan Y.M., Bajpai S.K. Magnetic nanoparticles for drug delivery applications. J Nanosci Nanotechnol 2008, 8:3247-3271.
5. Zhang L., Yu F., Cole A.J., Chertok B., David A.E., Wang J., et al. Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging. AAPS J 2009, 11:693-699.
6. Johannsen M., Gneveckow U., Eckelt L., Feussner A., Waldofner N., Scholz R., et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia 2005, 21:637-647.
7. Wilhelm C., Fortin J.P., Gazeau F. Tumour cell toxicity of intracellular hyperthermia mediated by magnetic nanoparticles. J Nanosci Nanotechnol 2007, 7:2933-2937.
8. Sun C., Lee J.S., Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008, 60:1252-1265.
9. Kohler N., Sun C., Fichtenholtz A., Gunn J., Fang C., Zhang M. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2006, 2:785-792.
10. Bruce I.J., Sen T. Surface modification of magnetic nanoparticles with alkoxysilanes and their application in magnetic bioseparations. Langmuir 2005, 21:7029-7035.
11. Wilhelm C., Gazeau F. Universal cell labelling with anionic magnetic nanoparticles. Biomaterials 2008, 29:3161-3174.
12. Osaka T., Matsunaga T., Nakanishi T., Arakaki A., Niwa D., Iida H. Synthesis of magnetic nanoparticles and their application to bioassays. Anal Bioanal Chem 2006, 384:593-600.
13. Dey T. Polymer-coated magnetic nanoparticles: surface modification and end-functionalization. J Nanosci Nanotechnol 2006, 6:2479-2483.
14. Gupta A.K., Naregalkar R.R., Vaidya V.D., Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2007, 2:23-39.
15. Lee S.Y., Harris M.T. Surface modification of magnetic nanoparticles capped by oleic acids: characterization and colloidal stability in polar solvents. J Colloid Interface Sci 2006, 293:401-408.
16. Flexman J.A., Minoshima S., Kim Y., Cross D.J. Magneto-optical labeling of fetal neural stem cells for in vivo MRI tracking. Conf Proc IEEE Eng Med Biol Soc 2006, 1:5631-5634.
17. Hoehn M., Kustermann E., Blunk J., Wiedermann D., Trapp T., Wecker S., et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 2002, 99:16267-16272.
18. Montet-Abou K., Montet X., Weissleder R., Josephson L. Cell internalization of magnetic nanoparticles using transfection agents. Mol Imaging 2007, 6:1-9.
19. McCarthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008, 60:1241-1251.
20. Guthi J.S., Yang S.G., Huang G., Li S., Khemtong C., Kessinger C.W., et al. MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. Mol Pharm 2010, 7:32-40.
21. Cinteza L.O., Ohulchanskyy T.Y., Sahoo Y., Bergey E.J., Pandey R.K., Prasad P.N. Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol Pharm 2006, 3:415-423.
22. Pradhan P., Giri J., Rieken F., Koch C., Mykhaylyk O., Doblinger M., et al. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release 2010, 14:108-121.
23. Shubayev V.I., Pisanic T.R., Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 2009, 61:467-477.
24. Rubio-Retama J., Zafeiropoulos N.E., Serafinelli C., Rojas-Reyna R., Voit B., Cabarcos E.L., et al. Synthesis and characterization of thermosensitive PNIPAM microgels covered with superparamagnetic gamma-Fe2O3 nanoparticles. Langmuir 2007, 23:10280-10285.
25. Wang L., Yang Z., Zhang Y., Wang L. Biofunctional nanoparticles with magnetization and luminescence. J Phys Chem C 2009, 113:3955-3959.
26. Guo R., Zhang L., Qian H., Li R., Jiang X., Liu B. Multifunctional nanocarriers for cell imaging, drug delivery, and near-IR photothermal therapy. Langmuir 2010, 26:5428-5434.
27. Yallapu M.M., Foy S.P., Jain T.K., Labhasetwar V. PEG-Functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pham Res 2010, 27:2283-2295.
28. Jain T.K., Morales M.A., Sahoo S.K., Leslie-Pelecky D.L., Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm 2005, 2:194-205.
29. Jain T.K., Reddy M.K., Morales M.A., Leslie-Pelecky D.L., Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm 2008, 5:316-327.
30. Gao J., Gu H., Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res 2009, 42:1097-1107.
31. Banerjee S.S., Chen D.-H. Magnetic nanoparticles grafted with cyclodextrin for hydrophobic drug delivery. Chem Mater 2007, 19:6345-6349.
32. Bhattarai S.R., Kc R.B., Kim S.Y., Sharma M., Khil M.S., Hwang P.H., et al. N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging. J Nanobiotechnology 2008, 6:1.
33. Yallapu M.M., Maher D.M., Sundram V., Bell M.C., Jaggi M., Chauhan S.C. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res 2010, 3:11.
34. Luo B., Song X.J., Zhang F., Xia A., Yang W.L., Hu J.H., et al. Multi-functional thermosensitive composite microspheres with high magnetic susceptibility based on magnetite colloidal nanoparticle clusters. Langmuir 2010, 26:1674-1679.
35. Beaven G.H., Chen S.-H., D'albis A., Gratzer W.B. A spectroscopic study of the haemin-human-serum-albumin system. Eur J Biochem 1974, 41:539-546.
36. Chipman D.M., Grisaro V., NSharon N. The binding of oligosaccharides containing N-acetylglucosamin and N-acetylmuramic acid to lysozyme. J Biol Chem 1967, 242:4388-4394.
37. Chauhan S.C., Vannatta K., Ebeling M.C., Vinayek N., Watanabe A., Pandey K.K., et al. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Res 2009, 69:765-774.
38. Yallapu M.M., Jaggi M., Chauhan S.C. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces 2010, 79:113-125.
39. Bae K.H., Ha Y.J., Kim C., Lee K.R., Park T.G. Pluronic/chitosan shell cross-linked nanocapsules encapsulating magnetic nanoparticles. J Biomater Sci Polym Ed 2008, 19:1571-1583.
40. Lim J.K., Majetich S.A., Tilton R.D. Stabilization of superparamagnetic iron oxide core-gold shell nanoparticles in high ionic strength media. Langmuir 2009, 25:13384-13393.
41. Lin J.J., Chen J.S., Huang S.J., Ko J.H., Wang Y.M., Chen T.L., et al. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials 2009, 30:5114-5124.
42. Xiong X.Y., Tam K.C., Gan L.H. Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles. J Control Release 2005, 103:73-82.
43. Dorris A., Rucareanu S., Reven L., Barrett C.J., Lennox R.B. Preparation and characterization of polyelectrolyte-coated gold nanoparticles. Langmuir 2008, 24:2532-2538.
44. Latham A.H., Williams M.E. Controlling transport and chemical functionality of magnetic nanoparticles. Acc Chem Res 2008, 41:411-420.
45. Peracchia M.T., Vauthier C., Puisieux F., Couvreur P. Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol). J Biomed Mater Res 1997, 34:317-326.
46. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
47. Billotey C., Wilhelm C., Devaud M., Bacri J.C., Bittoun J., Gazeau F. Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging. Magn Reson Med 2003, 49:646-654.
48. Smirnov P. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy. Methods Mol Biol 2009, 512:333-353.
49. Yallapu M.M., Gupta B.K., Jaggi M., Chauhan S.C. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci 2010.
50. Salomir R., Vimeux F.C., de Zwart J.A., Grenier N., Moonen C.T. Hyperthermia by MR-guided focused ultrasound: accurate temperature control based on fast MRI and a physical model of local energy deposition and heat conduction. Magn Reson Med 2000, 43:342-347.
51. Salomir R., Palussiere J., Vimeux F.C., de Zwart J.A., Quesson B., Gauchet M., et al. Local hyperthermia with MR-guided focused ultrasound: spiral trajectory of the focal point optimized for temperature uniformity in the target region. J Magn Reson Imaging 2000, 12:571-583.
52. Le Renard P.E., Jordan O., Faes A., Petri-Fink A., Hofmann H., Rufenacht D., et al. The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia. Biomaterials 2010, 31:691-705.
53. Le Renard P.E., Buchegger F., Petri-Fink A., Bosman F., Rufenacht D., Hofmann H., et al. Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model. Int J Hyperthermia 2009, 25:229-239.
54. Gentilini C., Evangelista F., Rudolf P., Franchi P., Lucarini M., Pasquato L. Water-soluble gold nanoparticles protected by fluorinated amphiphilic thiolates. J Am Chem Soc 2008, 130:15678-15682.
55. Latorre M., Rinaldi C. Applications of magnetic nanoparticles in medicine: magnetic fluid hyperthermia. P R Health Sci J 2009, 28:227-238.
56. Duguet E., Vasseur S., Mornet S., Devoisselle J.M. Magnetic nanoparticles and their applications in medicine. Nanomedicine 2006, 1:157-168.
57. Xia H.-B., Yi J., Foo P.-S., Liu B. Facile fabrication of water-soluble magnetic nanoparticles and their spherical aggregates. Chem Mater 2007, 19:4087-4091.
58. Kato H., Ishida T. Present and future status of noninvasive selective deep heating using RF in hyperthermia. Med Biol Eng Comput 1993, 31(Suppl.):S2-S11.
59. Motoyama J., Hakata T., Kato R., Yamashita N., Morino T., Kobayashi T., et al. Size dependent heat generation of magnetite nanoparticles under AC magnetic field for cancer therapy. Biomagn Res Technol 2008, 6:4.
60. Deger S., Taymoorian K., Boehmer D., Schink T., Roigas J., Wille A.H., et al. Thermoradiotherapy using interstitial self-regulating thermoseeds: an intermediate analysis of a phase II trial. Eur Urol 2004, 45:574-579. discussion 80.
61. Kawashita M., Tanaka M., Kokubo T., Inoue Y., Yao T., Hamada S., et al. Preparation of ferrimagnetic magnetite microspheres for in situ hyperthermic treatment of cancer. Biomaterials 2005, 26:2231-2238.
62. Serrano M.C., Portoles M.T., Pagani R., de Guinoa J.S., Ruiz-Hernandez E., Arcos D., et al. In vitro positive biocompatibility evaluation of glass-glass ceramic thermoseeds for hyperthermic treatment of bone tumors. Tissue Eng Part A 2008, 14:617-627.
63. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889-896.
64. Orrenius S., Zhivotovsky B. The future of toxicology-Does it matter how cells die?. Chem Res Toxicol 2006, 19:729-733.
65. Malugin A., Kopeckova P., Kopecek J. HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function. Mol Pharm 2006, 3:351-361.
66. McGowan A.J., Ruiz-Ruiz M.C., Gorman A.M., Lopez-Rivas A., Cotter T.G. Reactive oxygen intermediate(s) (ROI): common mediator(s) of poly(ADP-ribose)polymerase (PARP) cleavage and apoptosis. FEBS Lett 1996, 392:299-303.
67. de Murcia G., Menissier de Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 1994, 19:172-176.
68. Liu F., Park J.Y., Zhang Y., Conwell C., Liu Y., Bathula S.R., et al. Targeted cancer therapy with novel high drug-loading nanocrystals. J Pharm Sci 2010, 99:3542-3551.